Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma

Clinical Cancer Research, October 1, 2019

The cover shows a section of a tumor biopsy from a patient with malignant mesothelioma. Multiplex immunohistochemical staining reveals different immune cell populations infiltrating the tumor. 

Lab/Branch/Program: 
Thoracic and GI Malignancies Branch
Citation: 

R. Hassan, E. Alley, H. Kindler, S. Antonia, T. Jahan, S. Honarmand, N. Nair, C. C. Whiting, A. Enstrom, E. Lemmens, T. Tsujikawa, S. Kumar, G. Choe, A. Thomas, K. McDougall, A. L. Murphy, E. Jaffee, L. M. Coussens, D. G. Brockstedt, Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma. Clin Cancer Res 25, 5787-5798 (2019).

Published Date: 
October, 2019